Company Analysis

Curis, Inc. (CRIS)

Nasdaq: CRIS · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 2000
Grade4.1
◀ Past 3.4● Present 4.1▶ Future 4.5
1 est.

Who owns Curis, Inc.

As filed with the SEC
Holders of 5% or more
5
Nantahala Capital Management, LLC holds 9.99% of Common Stock, Par Value $0.01 per share, as its SCHEDULE 13G filed Apr 24, 2026 says.
Directors and officers
9
report now, of 18 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Nantahala Capital Management, LLC
SCHEDULE 13G · filed Apr 24, 2026 · Common Stock, Par Value $0.01 per share · 9.99% in Apr 7, 2026
9.99%
Thomas A. Satterfield, Jr.
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock, par value $0.01 per share · 9.9% in Apr 16, 2025
9.9%
Stonepine Capital Management, LLC
9.9%
Bleichroeder LP
9.9%
Nantahala Capital Partners Limited Partnership
SCHEDULE 13G · filed Apr 7, 2026 · Common Stock, Par Value $0.01 per share
6.98%
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, Par Value $0.01 per share · reported falling below 5%, from 9.99% in Feb 17, 2026
under 5%
M28 Capital Management LP
SCHEDULE 13G/A · filed Jan 23, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.9% in Aug 13, 2025
under 5%
Maverick Capital, Ltd.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%, from 8% in Feb 14, 2025
under 5%
What CRIS reports owning in othersstakes of 5% or more, and other ties

1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 24, 2026.

Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
16171920212226
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 21 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Kaitin Kenneth Idirector0$001$0
SI Assistanton CRIS · research, not advice